Gemcitabine May Hold Promise for BCG Failures - Renal and Urology News
Links shared publicly online about this topic.
- 1,277total visits
Gemcitabine May Hold Promise for BCG Failures - Renal and Urology News
Gemcitabine might be a second-line treatment option for patients with high-risk non-muscle-invasive bladder cancer (BC) who fail therapy with bacille Calmette-Gurin (BCG), according to Italian researchers.
View full resource at renalandurologynews.com
Tags: Cancer Medication, Bladder Cancer, Kidney Health, Urinary System, Gemzar, Urology, News
Most Recently Shared on March 30, 2010 at 5:14 pm By:
Gemcitabine May Hold Promise for BCG Failures: Gemcitabine might be a second-line treatment option for patients wi... http://bit.ly/cOMQcN
Advertisement
